We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

MedImaging

Download Mobile App
Recent News Radiography MRI Ultrasound Nuclear Medicine General/Advanced Imaging Imaging IT Industry News

Microstructure Imaging Solution Detects Prostate Cancer

By MedImaging International staff writers
Posted on 10 Dec 2019
Print article
Image: RSI-MRI+ increases the visibility of restricted water in prostate tumors (Photo courtesy of HealthLytix)
Image: RSI-MRI+ increases the visibility of restricted water in prostate tumors (Photo courtesy of HealthLytix)
Novel imaging software based on advanced diffusion magnetic resonance imaging (MRI) increases the visibility of restricted water, a hallmark of cancerous tissue.

The HealthLytix (San Diego, CA, USA) RSI-MRI+ system uses an advanced multi-compartment diffusion model that combines restriction spectrum imaging (RSI) MRI, biophysical models, and artificial intelligence (AI) algorithms to interrogate prostate tissue microstructure and improve the conspicuity of restricted water diffusion, compared to standard high b-value diffusion-weighted imaging (DWI). AI algorithms then automatically segment the prostate on anatomical T2-weighted images, issuing a quantitative report that correlates with total prostate volume (in mL).

The resulting restricted signal map is subsequently fused with the patients anatomical T2-weighted MRI scan to support anatomical localization along with the image segmentation results, all in order to verify segmentation accuracy. RSI-MRI+ can thus provide a general in-vivo framework for estimating tissue properties from DWI data and can provide an in-vivo measure of tumor cells, resulting from its ability to distinguish separable pools of water within tissue, based on their intrinsic diffusion characteristics.

“A key innovation of RSI-MRI+ is that it can better characterize the complexity of water diffusion in cancerous tissue, resulting in better performance,” said Nathan White, PhD, co-inventor of RSI and CEO of HealthLytix. “With early-stage aggressive cancer, we need more sophisticated approaches to separate what's important from what's not important. In cancer, that means separating restricted diffusion from other sources of water diffusion that are less relevant.”

RSI-MRI is designed to improve upon the strengths of conventional MRI while correcting its weaknesses. The goal of RSI-MRI is improved conspicuity of highly cellular tumors by modeling water compartments in tissue made possible by obtaining an extended spectrum of diffusion images. By focusing on the signal arising from intracellular water, the technique in effect images cellularity; highly cellular tumors are thus highlighted. In addition, RSI-MRI corrects the often considerable distortion observed with conventional DWI methods, beneficial in the identification of tumor extension beyond the confines of the prostate.

Related Links:
HealthLytix

New
HF Stationary X-Ray Machine
TR20G
X-ray Diagnostic System
FDX Visionary-A
40/80-Slice CT System
uCT 528
Ultrasound Table
Women’s Ultrasound EA Table

Print article

Channels

MRI

view channel
Image: The AI tool can help interpret and assess how well treatments are working for MS patients (Photo courtesy of Shutterstock)

AI Tool Tracks Effectiveness of Multiple Sclerosis Treatments Using Brain MRI Scans

Multiple sclerosis (MS) is a condition in which the immune system attacks the brain and spinal cord, leading to impairments in movement, sensation, and cognition. Magnetic Resonance Imaging (MRI) markers... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more